Block of proliferation 1 promotes cell migration and invasion in human colorectal cancer cells via the JNK pathway
Authors:
Open Access
- 13 March 2020
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 34 (7) , e23283
Abstract
Metastasis is one of the most common causes of death in patients with colorectal cancer (CRC). Block of proliferation 1 (BOP1) regulates tumorigenesis, epithelial‐to‐mesenchymal transition, migration, metastasis, and drug resistance in several tumor types. However, the role of BOP1 in the regulation of colorectal cancer cell migration and invasion is still largely unclear. In this study, the results of immunohistochemistry showed that BOP1 was upregulated in our cohort of CRC patients. BOP1 knockdown inhibited the migration and invasion of CRC cells, confirmed by the downregulation of the mRNA levels of MMP‐2 and MMP‐9. The overexpression of BOP1 in CRC cells exerted the opposite effect. SP600125, an inhibitor of JNK signaling, partially abolished the BOP1 overexpression‐mediated increase in the migratory and invasive ability of CRC cells. Our results indicated that BOP1 is an important regulator of CRC cell invasion and migration, predominantly through the JNK signaling pathway.Keywords
This publication has 23 references indexed in Scilit:
- Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastasesProceedings of the National Academy of Sciences, 2015
- SOX2 Enhances the Migration and Invasion of Ovarian Cancer Cells via Src KinasePLOS ONE, 2014
- The Role of Matrix Metalloproteinases in Colorectal CancerCancers, 2014
- Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transitionHepatology, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Molecular Basis of Colorectal CancerNew England Journal of Medicine, 2009
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studiesThe Lancet, 2008
- PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patientsBritish Journal of Cancer, 2007
- Contribution of theBOP1 gene, located on 8q24, to colorectal tumorigenesisGenes, Chromosomes and Cancer, 2006
- Epithelial–mesenchymal transitions in tumour progressionNature Reviews Cancer, 2002